ImageneBio Inc
52 hedge funds and large institutions have $205M invested in ImageneBio Inc in 2023 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 19 increasing their positions, 7 reducing their positions, and 4 closing their positions.
325% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 4
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
171% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 7
137% more capital invested
Capital invested by funds: $86.2M → $205M (+$118M)
33% more funds holding
Funds holding: 39 → 52 (+13)
0.39% more ownership
Funds ownership: 5.74% → 6.13% (+0.39%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$10.5M |
| 2 |
ACA
Avoro Capital Advisors
New York
|
+$9.8M |
| 3 |
BlackRock
New York
|
+$5.74M |
| 4 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$3.33M |
| 5 |
CA
CHI Advisors
New York
|
+$2.76M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Verition Fund Management
Greenwich,
Connecticut
|
-$3.2M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$848K |
| 3 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$390K |
| 4 |
Millennium Management
New York
|
-$376K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$137K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
US Bancorp
Minneapolis,
Minnesota
| $1.43K | – | – | – |
|
|
FFA
52
Farther Finance Advisors
San Francisco,
California
| $328 | – | – | – |
|
|
DCM
53
DAFNA Capital Management
Los Angeles,
California
| – | -$390K | -9,411 | Closed |
|
|
54
Millennium Management
New York
| – | -$376K | -9,073 | Closed |
|
|
55
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$137K | -3,311 | Closed |
|
56
Jane Street
New York
| – | -$132K | -3,193 | Closed |
|
IMA Hedge Fund Activity: Q2 2023 in Review
52 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in ImageneBio Inc (IMA) for Q2 2023, worth a combined $205M — up 137% from $86.2M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new IMA positions and 4 closed out — a net gain of 13 holders — while 19 added to existing stakes and 7 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $10.5M. The largest seller was Verition Fund Management, cutting an estimated $3.2M.
- 52 institutional investors held ImageneBio Inc (IMA) as of Q2 2023, up from 39 in Q1 2023.
- Funds reported $205M of ImageneBio Inc stock for Q2 2023, up 137% quarter-over-quarter.
- 17 funds opened new ImageneBio Inc positions in Q2 2023 and 4 closed out, a net change of +13 holders.
- The largest ImageneBio Inc buyer in Q2 2023 was Fidelity Investments, an estimated $10.5M added.
- The largest ImageneBio Inc seller in Q2 2023 was Verition Fund Management, an estimated $3.2M sold.
Based on aggregated 13F filings for Q2 2023.